基于机器学习的早孕期母体特征与生物标志物对子痫前期的预测
该研究基于英国两家产科医院11–13周前瞻性非干预性筛查数据,采用人工神经网络结合母体特征、病史及生物标志物预测子痫前期。模型对早产子痫前期预测在10%假阳性率下检出率75.3%、AUC 0.909;去除种族信息后检出率降至55.0–62.1%。
要点
- 早产子痫前期预测:10%假阳性率下,母体因素联合生物标志物检出率75.3%、AUC 0.909。
- 仅母体因素筛查早产子痫前期:10%假阳性率下检出率53.3%、AUC 0.816。
- 去除种族信息训练模型后,早产子痫前期检出率降至55.0–62.1%(联合生物标志物)。
核心结论
- 基于非线性机器学习的方法筛查子痫前期无需人群标准化,性能与逻辑回归相似。
- 从模型中去除种族信息会降低预测准确性,尤其当仅考虑母体因素时对非白人人群影响更明显。
研究设计与样本
- 数据来自英国两家产科医院11–13周妊娠的前瞻性非干预性子痫前期筛查。
- 数据分为三部分:30 437例用于开发训练,10 000例用于优化机器学习超参数,20 352例用于模型验证。
- 使用人工神经网络从人口学特征和病史预测先验风险,再结合生物标志物值确定子痫前期及<37周分娩的早产子痫前期风险。
- 另训练一个不包含种族作为输入的神经网络。
- 生物标志物包括子宫动脉搏动指数(UtA-PI)、平均动脉压(MAP)、胎盘生长因子(PlGF)和妊娠相关血浆蛋白-A,均使用原始值而未转换为标准化中位数倍数。
主要发现
- 早产子痫前期 vs 无子痫前期,10%假阳性率下,仅母体因素筛查检出率53.3%、AUC 0.816;加入生物标志物后检出率75.3%、AUC 0.909。
- 不将种族用于训练模型时,10%假阳性率下,仅母体因素筛查早产子痫前期 vs 无子痫前期的检出率降至34.5–45.5%(不同种族),加入生物标志物后为55.0–62.1%。
- 子痫前期的主要预测因素为高MAP、高UtA-PI和低PlGF。
- 全部子痫前期 vs 无子痫前期,仅母体因素筛查AUC 0.770、10%假阳性率下检出率41.3%;加入生物标志物后AUC 0.817、检出率52.9%。
- 对全部子痫前期的预测准确性低于对早产子痫前期的预测。
关键数值与推荐
- 早产子痫前期预测:仅母体因素10%假阳性率下检出率53.3%(AUC 0.816),联合生物标志物75.3%(AUC 0.909)。
- 去除种族信息后早产子痫前期检出率:仅母体因素34.5–45.5%(不同种族),联合生物标志物55.0–62.1%(10%假阳性率)。
- 全部子痫前期预测:仅母体因素10%假阳性率下检出率41.3%(AUC 0.770),联合生物标志物52.9%(AUC 0.817)。
- 推荐对早产子痫前期高风险病例使用阿司匹林。
临床怎么用
- 早孕期筛查可基于母体特征、病史与生物标志物,采用机器学习方法预测子痫前期风险,无需人群标准化。
- 推荐对早产子痫前期高风险病例使用阿司匹林。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the accuracy of predicting the risk of developing pre-eclampsia (PE) according to first-trimester maternal demographic characteristics, medical history and biomarkers using artificial-intelligence and machine-learning methods. METHODS: The data were derived from prospective non-interventional screening for PE at 11-13 weeks' gestation at two maternity hospitals in the UK. The data were divided into three subsets. The first set, including 30 437 subjects, was used to develop the training process, the second set of 10 000 subjects was utilized to optimize the machine-learning hyperparameters and the third set of 20 352 subjects was coded and used for model validation. An artificial neural network was used to predict from the demographic characteristics and medical history the prior risk that was then combined with biomarker values to determine the risk of PE and preterm PE with delivery at < 37 weeks' gestation. An additional network was trained without including race as input. Biomarkers included uterine artery pulsatility index (UtA-PI), mean arterial blood pressure (MAP), placental growth factor (PlGF) and pregnancy-associated plasma protein-A. All markers were entered using raw values without conversion into standardized multiples of the median. The prediction accuracy was estimated using the area under the receiver-operating-characteristics curve (AUC). We further computed the detection rate at 10%, 20% and 40% false-positive rates (FPR). The impact of taking aspirin was also added. Shapley values were calculated to evaluate the contribution of each parameter to the prediction of risk. We used a non-parametric test to compare the expected AUC with the one obtained when we randomly scrambled the labels and kept the predictions. For the general prediction, we performed 10 000 permutations of the labels. When the AUC was higher than the one obtained in all 10 000 permutations, we reported a P-value of < 0.0001. For the race-specific analysis, we performed 1000 permutations. When the AUC was higher than the AUC in permutations, we reported a P-value of < 0.001. RESULTS: The detection rate for preterm PE vs no PE, at a 10% FPR, was 53.3% when screening by maternal factors only, and the corresponding AUC was 0.816; these increased to 75.3% and 0.909, respectively, with the addition of biomarkers into the model. Information on race was important for the prediction accuracy; when race was not used to train the model, at a 10% FPR, the detection rate of preterm PE vs no PE decreased to 34.5-45.5% (for different races) when screening by maternal factors only and to 55.0-62.1% when biomarkers were added. The major predictors of PE were high MAP and UtA-PI, and low PlGF. The accuracy of prediction of all PE cases was lower than that for preterm PE. Aspirin use was recommended for cases who were at high risk of preterm PE. The AUC of all PE vs no PE was 0.770 when screening by maternal factors and 0.817 when the biomarkers were added; the respective detection rates, at a 10% FPR, were 41.3% and 52.9%. CONCLUSIONS: Screening for PE using a non-linear machine-learning-based approach does not require a population-based normalization, and its performance is similar to that of logistic regression. Removing race information from the model reduces its prediction accuracy, especially for the non-white populations when only maternal factors are considered. © 2022 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Ansbacher-Feldman Z, Syngelaki A, Meiri H, et al. Machine-learning-based prediction of pre-eclampsia using first-trimester maternal characteristics and biomarkers. Ultrasound Obstet Gynecol. 2022. PMID: 36454636. doi:10.1002/uog.26105
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。